The Interactive Pharma Scandal Story - October 08, 2008
Big-pharma is in the dock again today as Pfizer stands accused of manipulating publication of data on its drug Neurontin. This is according to experts who have combed through company documents for plantiffs who are suing the company. Pfizer has denied the plantiffs charges, says the Boston Globe.
Kay Dickersin, of Johns Hopkins Bloomberg School of Public Health, says the documents show “a publication strategy meant to convince physicians of Neurontin’s effectiveness and misrepresent or suppress negative findings” (NY Times).
Reuters says:
The documents suggest that Pfizer's marketers influenced Neurontin's scientific record to boost sales at least until 2003 by delaying the publication or altering the conclusions of studies that had found no evidence the drug worked for various conditions besides epilepsy.
As news breaks of another potential pharma scandal, The Great Beyond is resurrecting our interactive political interference story. We present to you: The Interactive Pharma Scandal Story.
NOTE: ALL DATA IN THIS IS DRAWN FROM ACTUAL CASES. HOWEVER IT IS NOT TRUE IN ALL COMBINATIONS AND SHOULD NOT BE TAKEN TO REPRESENT ACTUAL PAST OR FUTURE SCANDALS.
The Interactive Pharma Scandal StoryIt was revealed today by
that
had
in relation to its drug
Commentators expressed their
The company has
Let us know if you'd like more options added...
